Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jun;26(2):115-117.
doi: 10.15403/jgld.2014.1121.262.hpy.

It is time to rethink H. pylori therapy

Affiliations
Editorial

It is time to rethink H. pylori therapy

Bich N Dang et al. J Gastrointestin Liver Dis. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Dr. Dang has no conflicts to declare.

Comment on

References

    1. Di Ciaula A, Scaccianoce G, Venerito M, et al. Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe. J Gastrointestin Liver Dis 2017;26. - PubMed
    1. Graham DY, Dore MP. Helicobacter pylori therapy: a paradigm shift. Expert Rev Anti Infect Ther 2016;14:577–585. doi: 10.1080/14787210.2016.1178065 - DOI - PMC - PubMed
    1. Dang BN, Graham DY. Helicobacter pylori infection and antibiotic resistance: a WHO high priority? Nat Rev Gastroenterol Hepatol 2017. May 3. doi: 10.1038/nrgastro.2017.57 - DOI - PMC - PubMed
    1. Yamaoka Y, Graham DY, Lu H. Should triple therapy for Helicobacter pylori infection be abandoned as no longer effective? US Gastroenterology 2008;4:65–67.
    1. Della Monica P, Lavagna A, Masoero G, Lombardo L, Crocella L, Pera A. Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy. Aliment Pharmacol Ther 2002;16:1269–1275. doi: 10.1046/j.1365-2036.2002.01244.x - DOI - PubMed